Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navdeep Tangri

Showing results (391-400 of 410) with videos related to

Pageof 41
Sort By:
Medicine|February 3, 2017
Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practicesTariq Shafi, Stephen M Sozio, Jason Luly, et al.
The Lancet. Diabetes & Endocrinology|June 20, 2020
Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort studyShun Kohsaka, Carolyn S P Lam, Dae Jung Kim, et al.
Canadian Journal of Kidney Health and Disease|November 21, 2022
Involving Patient Partners in the KRESCENT Peer Review: Intent, Process, Challenges, and OpportunitiesElisabeth A Fowler, Karin Bell, Kevin Burns, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 27, 2022
Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational studyMin Jun, Anish Scaria, Jason Andrade, et al.
Kidney360|April 9, 2025
Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation: A Binational Population-Based StudyDickson Lam, Anish Scaria, Jason Andrade, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 3, 2022
A National Registry for People With All Stages of Kidney Disease: The National Kidney Foundation (NKF) Patient NetworkLesley A Inker, Silvia Ferrè, Mary Baliker, et al.
Kidney Medicine|July 26, 2023
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and CanadaJeffrey T Ha, Anish Scaria, Jason Andrade, et al.
Cardiovascular Diabetology|August 1, 2021
Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL dataKamlesh Khunti, Mikhail Kosiborod, Dae Jung Kim, et al.
Kidney Medicine|July 31, 2025
Gender-affirming Hormone Therapy and Changes in Kidney Function in Adults: A Retrospective Population-based StudySilvia J Leon, Thomas W Ferguson, Reid Whitlock, et al.
Kidney Medicine|August 17, 2021
Integrated Digital Health System Tools to Support Decision Making and Treatment Preparation in CKD: The PREPARE NOW StudyJamie A Green, Patti L Ephraim, Felicia Hill-Briggs, et al.
Pageof 41

Showing results (391-400 of 410) with videos related to

Sort By:
Pageof 41
Medicine|February 3, 2017
Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practicesTariq Shafi, Stephen M Sozio, Jason Luly, et al.
The Lancet. Diabetes & Endocrinology|June 20, 2020
Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort studyShun Kohsaka, Carolyn S P Lam, Dae Jung Kim, et al.
Canadian Journal of Kidney Health and Disease|November 21, 2022
Involving Patient Partners in the KRESCENT Peer Review: Intent, Process, Challenges, and OpportunitiesElisabeth A Fowler, Karin Bell, Kevin Burns, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 27, 2022
Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational studyMin Jun, Anish Scaria, Jason Andrade, et al.
Kidney360|April 9, 2025
Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation: A Binational Population-Based StudyDickson Lam, Anish Scaria, Jason Andrade, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 3, 2022
A National Registry for People With All Stages of Kidney Disease: The National Kidney Foundation (NKF) Patient NetworkLesley A Inker, Silvia Ferrè, Mary Baliker, et al.
Kidney Medicine|July 26, 2023
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and CanadaJeffrey T Ha, Anish Scaria, Jason Andrade, et al.
Cardiovascular Diabetology|August 1, 2021
Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL dataKamlesh Khunti, Mikhail Kosiborod, Dae Jung Kim, et al.
Kidney Medicine|July 31, 2025
Gender-affirming Hormone Therapy and Changes in Kidney Function in Adults: A Retrospective Population-based StudySilvia J Leon, Thomas W Ferguson, Reid Whitlock, et al.
Kidney Medicine|August 17, 2021
Integrated Digital Health System Tools to Support Decision Making and Treatment Preparation in CKD: The PREPARE NOW StudyJamie A Green, Patti L Ephraim, Felicia Hill-Briggs, et al.
Pageof 41